Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort studyDavid Hillus, Anne‐Katrin Fietz, Christian Hoffmann et al.|The Lancet Infectious Diseases|2025Cited by 26
Validation of a new prognostic body composition parameter in cancer patients.Paolo Pedrazzoli, Emanuele Cereda, Riccardo Caccialanza et al.|Journal of Clinical Oncology|2019Cited by 0